Evaluation of tissue PCA3 expression in prostate cancer by RNA in situ hybridization- a correlative study with urine PCA3 and TMPRSS2-ERG

被引：26
|
作者：
Warrick, Joshua I. [1 ]
Tomlins, Scott A. [1 ,2 ,3 ,4 ]
Carskadon, Shannon L. [1 ,2 ]
Young, Allison M. [1 ]
Siddiqui, Javed [1 ,2 ]
Wei, John T. [4 ]
Chinnaiyan, Arul M. [1 ,2 ,3 ,4 ,5 ]
Kunju, Lakshmi P. [1 ,2 ,3 ]
Palanisamy, Nallasivam [1 ,2 ,3 ]
机构：
[1] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48104 USA
[2] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI USA
[3] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI USA
[4] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI USA
[5] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA
来源：
MODERN PATHOLOGY | 2014年 / 27卷 / 04期
基金：
美国国家卫生研究院;
关键词：
PCA3; prostate cancer; RNA in situ hybridization; ANTIBODY-BASED DETECTION; ETS GENE FUSIONS; INTRAEPITHELIAL NEOPLASIA; ANTIGEN; REARRANGEMENT STATUS; TMPRSS2/ERG; CARCINOMA; DD3;
D O I：
10.1038/modpathol.2013.169
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
PCA3 is a prostate-specific non-coding RNA, with utility as a urine-based early detection biomarker. Here, we report the evaluation of tissue PCA3 expression by RNA in situ hybridization in a cohort of 41 mapped prostatectomy specimens. We compared tissue PCA3 expression with tissue level ERG expression and matched pre-prostatectomy urine PCA3 and TMPRSS2-ERG levels. Across 136 slides containing 138 foci of prostate cancer, PCA3 was expressed in 55% of cancer foci and 71% of high-grade prostatic intraepithelial neoplasia foci. Overall, the specificity of tissue PCA3 was >90% for prostate cancer and high-grade prostatic intraepithelial neoplasia combined. Tissue PCA3 cancer expression was not significantly associated with urine PCA3 expression. PCA3 and ERG positivity in cancer foci was positively associated (P<0.01). We report the first comprehensive assessment of PCA3 expression in prostatectomy specimens, and find limited correlation between tissue PCA3 and matched urine in prostate cancer.
引用
收藏
页码：609 / 620
页数：12
相关论文
共 50 条
  • [21] Controversies in using urine samples for Prostate Cancer detection: PSA and PCA3 expression analysis
    Fontenete, S.
    Silva, J.
    Teixeira, A. L.
    Ribeiro, R.
    Bastos, E.
    Pina, F.
    Medeiros, R.
    INTERNATIONAL BRAZ J UROL, 2011, 37 (06): : 719 - 726
  • [22] The role of prostate cancer antigen 3 (PCA3) in prostate cancer detection
    Ploussard, Guillaume
    de la Taille, Alexandre
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (10) : 1013 - 1020
  • [23] Prognostic and predictive molecular biological markers in prostate cancer - significance of expression of genes PCA3 and TMPRSS2
    Soumarova, R.
    Boday, A.
    Krhutova, V.
    Janotova, A.
    Dvorakova, M.
    Jaluvkova, E.
    Stursa, M.
    Perkova, H.
    NEOPLASMA, 2015, 62 (01) : 114 - 118
  • [24] Urine TMPRSS2:ERG fusion transcript integrated with PCA3 score, genotyping, and biological features are correlated to the results of prostatic biopsies in men at risk of prostate cancer
    Cornu, Jean-Nicolas
    Cancel-Tassin, Geraldine
    Egrot, Christophe
    Gaffory, Cecile
    Haab, Francois
    Cussenot, Olivier
    PROSTATE, 2013, 73 (03) : 242 - 249
  • [25] Diagnostic potential value of circulating PCA3 mRNA in plasma and urine of prostate cancer patients
    Akinloye, Oluyemi
    Kareem, Olatunji I.
    Popoola, Olayiwola A.
    Samuel, Titilola A.
    Adaramoye, Oluwatosin
    SCIENTIFIC AFRICAN, 2022, 17
  • [26] PCA3 is a true oncomarker of prostate cancer: a review of literature
    Sidorenkov, A. V.
    Pushkar, D. Yu.
    ONKOUROLOGIYA, 2014, 10 (02): : 70 - 77
  • [27] PSA, PCA3 and the phi losophy of prostate cancer management
    Melichar, Bohuslav
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2013, 51 (04) : 707 - 712
  • [28] Urinary PCA3 test, prostate cancer and other prostatic diseases
    Vlaeminck-Guillem, V.
    IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE, 2012, 27 (03): : 104 - 111
  • [29] Possibility of using PCA3 score without prostate massage in urine for diagnosing prostate cancer
    Musaelyan, A. A.
    Nazarov, V. D.
    Lapin, S., V
    Pavlova, O. N.
    Viktorov, D. A.
    Boriskin, A. G.
    Reva, S. A.
    Petrov, S. B.
    ONKOUROLOGIYA, 2020, 16 (04): : 82 - 88
  • [30] Urinary PCA3 to predict prostate cancer in a cohort of 1015 patients
    Vlaeminck-Guillem, V.
    Devonec, M.
    Champetier, D.
    Decaussi-Petrucci, M.
    Paparel, P.
    Perrin, P.
    Ruffion, A.
    PROGRES EN UROLOGIE, 2015, 25 (16): : 1160 - 1168
12345